DovaVision BE

Diagnostics and imaging · by Dova Health Intelligence

AI-powered real-time Barrett's Esophagus surveillance and early esophageal adenocarcinoma (EAC) detection.

What it does

AI-powered real-time Barrett's Esophagus surveillance and early esophageal adenocarcinoma (EAC) detection. Provides dynamic frame-level detection, granular mapping of dysplastic vs. non-dysplastic tissue, and integrated QA and reporting. FDA Breakthrough Device Designation.

  • AI-driven endoscopic disease severity assessment for Ulcerative Colitis
  • Real-time Barrett's Esophagus surveillance and early EAC detection
  • Intestinal ultrasound analysis for IBD assessment
Category
Diagnostics and imaging
Built for
Healthcare and life sciences
Users
Researchers, Clinical practitioners, Pharma and clinical trial teams
Public API
Not offered
Deployment
On-premises

Not yet disclosed: platforms, languages and support channels.

Pricing

Pricing isn't published

Dova Health Intelligence doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by Dova Health Intelligence. Ask for audit reports before you buy.

  • ISO 9001Certified

Reviews

No reviews yet

Reviews come from people who use DovaVision BE at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim DovaVision BE